<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Ziki - GABRIEL CARNEY's last published content</title>
    <link>http://www.ziki.com/en/gabriel-carney-1+1128818</link>
    <pubDate>Sat, 21 Apr 2012 01:20:00 +0200</pubDate>
    <ttl>120</ttl>
    <description>My aggregated content at ziki.com</description>
    <item>
      <title>Regenerative Medicine and the Promise of Stem Cell Research</title>
      <link>http://www.ziki.com/en/gabriel-carney-1+1128818/post/regenerative-medicine-and-the-promise-of-stem-cell-research+14365614</link>
      <description>
        <![CDATA[<div class="post_content wiki_text"> Not such a big deal: - <br /> <br /> "Compulsory Licensing" will require poor countries like Kenya, Uganda or South Africa- unable to copy patented medicines to fight scourges like Aids-importing cheaper copies from India. The concerned governments will need to sure public d to those that need such medicines thereby money needed for Imports. Therefore the afflicted countries will need to depend on rich country donors to uncover tho money. Alternatively, they can approach world bodies which might be again funded by rich countries, As such, despite the fact that the margin (change in prices between patented drugs end Indian copies) may be fairly high, these are not really "lucrative" markets. There are also at the vexed doubts of red tape and government inefficiency. <br /> <br /> Examine Ourselves: - <br /> <br /> This paper is related to valuing IP assets; it is about how these assets ought to be valued in the context of external financial confirming. The generation of useful estimates of lP value is also of crucial importance inside context of internal confirming. But internal reporting usually requires valuation parameters or indicators which were different from those used when considering external reporting. Internal reporting is outside the purview of this cardstock. <br /> <br /> Asset Value Practices <br /> <br /> Asset valuation for a start requires asset recognition. Option pricing models attempt to estimate the economic values for these possible choices.  <br /> The pick of valuation methods should not be arbitrary. It should be determined by the company characteristics and by just how the company delivers its product or service. If the value assigned to lP assets cannot be incorporated in the balance sheet for specialized reasons, the information may very well be provided on a supplementary basis. But this ought to be done in a systematic and consistent way. <br /> <br /> Assigning a value on lP assets is a challenging job. It is a challenging job particularly when the exercise has to be done in the circumstance of preparation and speech of external financial statements. But the accounting profession should anticipate to ac cept the obstacle. There is also the possibility that many companies may have to spend considerable period of time and money in order to determine how or whether to carry on research without your infringement of others' obvious rights, or allowing others to infringement upon their own personal patent rights The benefits arising out of such expenditure of time and money ought to be weighed against the huge costs linked to patent litigation and efforts ought to be made to reduce these non-productive/less-productive expenditure.  <br /> your formulation of lPR insurance coverage, and those of the final consumers are pushed to the hedge. The developing countries operate with a weaker position while negotiating along with the developed countries in matters associated with lPRs, Thus, policy makers should really examine the possible effects of implementation of the IPRs on the ultimate consumers before going for further extension with IPRs instead of simply taking care of the interests of that owners/creators of lPRs, <br /> <br /> The crux of the whole lot is that the commercial interests of the developed world often come in conflict with the developmental needs with the developing countries. What is important is that too high IPR standards really should not be indiscriminately imposed on that developing countries and relevant technologies should be made available to them at competitive prices. The developing countries must also strongly put up their causes in different world forum and nations like India and China are anticipated to play a leading role from this respect. <br /> <br /> References: -(1)Adapted With Website Of Policy Statement Of Embassy Of India. <br />Detailed information on <a href="http://www.ipsctherapy.com">iPSC Therapy</a> can be found at main website.</div>]]>
      </description>
      <pubDate>Sat, 21 Apr 2012 01:20:00 +0200</pubDate>
      <guid isPermaLink="false">tag:ziki.com,2012:/article/14365614</guid>
    </item>
    <item>
      <title>Intellectual Property and Its Pervasiveness in Industry Trade and Commerce</title>
      <link>http://www.ziki.com/en/gabriel-carney-1+1128818/post/intellectual-property-and-its-pervasiveness-in-industry-trade-and-commerce+14337683</link>
      <description>
        <![CDATA[<div class="post_content wiki_text">This is an important reason so why most internally developed lP assets are not reported on the stabilize sheet. Accounting standard setters are grappling while using the issue, but the mismatch between accounting principles and the appropriate valuation of IP and similar assets continues to exist. They are yet to cultivate an acceptable basis for solving the challenge of trade-off between meaning and reliability. <br /> <br /> lP assets are different in many significant respects in the traditional assets. Many of IP assets are contexts certain. In most cases, the actual value of an lP asset depends to a great extent upon the ability of the company owning the asset to make use of it efficiently and effectively. The value in most cases also will depend on the ability of the organization to exclude others from with the asset. Because of this, it becomes. often difficult to ascertain reliable ways of determining values to IP means. Considerable research in modern times has gone into solving the problems of valuation of lP and other intangible assets and, consequent upon which, some valuation models have been completely developed (e. grams., Intangible Assets Monitor associated with Sveiby, the Skandia Model and also the Balanced Scorecard of Kaplan together with Norton). But none has gained common acceptance. <br /> <br /> Alternative Value Approaches: - <br /> <br /> There are a number of tested ways with valuing IP. While choosing a valuation method a company should firstly determine how the tool being valued will create value because of it. An asset may create value due to the owner by generating additional revenues, by saving costs or by giving competitive advantage. It is the way an asset creates value for any owner which should ascertain which valuation approach is usually to be adopted. An overview of possible valuation approaches is usually provided below. <br /> <br /> (1) Reduced Cash Flow(DCF) Strategy: - <br /> <br /> The DCF approach is regarded as an ideal process for valuation of possessions. At the most fundamental level, the value of an asset depends upon three factors; how much it's expected to generate in cash flows; the timings of generation these cash flows; and the degree of uncertainty from the cash flows. The DCF approach takes into consideration all these factors. Under this process, the value of an asset is a discounted present value involving its estimated future cash flows. To apply this valuation approach necessary to examine the conditions under the fact that lP asset will use and to develop an agreed basis for predicting future earnings and expenditures attached to the asset. The projected amounts are then discounted by employing an appropriate discount factor. The success of this approach depends on the accuracy with which the future cash flow projections are made. <br /> <br /> (two) Excess Operating Income Approach: - <br /> <br /> The excess operating profits approach determines the value of an IPR asset by capitalizing the excess profits the business expects to generate thanks to the asset. There are several ways that they the excess profits may be calculated. One possible way of computation of such profits is always to make estimates of profits the business enterprise would earn without that asset., i. e. to speak about the profit the firm would earn in the normal course of company had the IPR being not inducted in the business. <br /> <br /> (3)Replacement Expense Approach: - <br />Detailed information on <a href="http://www.ipsctherapy.com">Induced Pluripotent Stem Cell therapy</a> can be found at main website.</div>]]>
      </description>
      <pubDate>Tue, 17 Apr 2012 21:42:15 +0200</pubDate>
      <guid isPermaLink="false">tag:ziki.com,2012:/article/14337683</guid>
    </item>
  </channel>
</rss>
